Morgan Lewis

Related Publications

02/09/12 FDA Issues Three Draft Guidances for Biosimilars
Initial guidance provides insights on regulatory pathway for biosimilars, but does not address many critical issues.
01/11/12 FDA Gets (Un)Social
FDA draft guidance on responding to requests for off-label information foreshadows restrictive policies on use of social media.
05/23/11 FDA Requests Comments on the Development of a User Fee Program for Biosimilar and Interchangeable Biological Products
View all publications

Related News

05/28/10 Attorneys See Uncertainty in FDA's Implementation of Biosimilar Approvals, Life Sciences Law & Industry Report
09/24/09 Morgan Lewis Advises LEO Pharma on $1 Billion Acquisition
Morgan Lewis represented LEO Pharma in the $1 billion acquisition of exclusive product licensing rights and inventories from LEO Pharma by Warner Chilcott plc.
12/20/06 Morgan Lewis's Life Sciences Practice Recognized in PLCCross-border Life Sciences Handbook
Morgan Lewis is pleased to announce that the Life Sciences Interdisciplinary Practice and several of its attorneys are recognized in the PLCCross-border Life Sciences Handbook 2006/07.
View all news
Your message will be sent to: Kathleen M. Sanzo